BioSpace News Archive

Company to expand the use of its PROZOR implant technology by building on the success with its lead antipsychotic program

Technology-Enabled Care Collaboration Anticipated to Enhance ICU Health Outcomes While Decreasing Patient Length of Stay

In support of World Arthritis Day, which is celebrated every October 12 to raise awareness of arthritis, Bioventus, a global leader in orthobiologics, has launched a disease and product information website called OAKneePainRelief.com which combines information on knee osteoarthritis (OA) for both patients and health care providers (HCPs) with the full Bioventus portfolio of hyaluronic acid (HA)-based joint-fluid treatment options.

Scandinavian ChemoTech (ChemoTech) has today announced that the company has received the final notice from the Swedish patent Authorities (PRV) for two of its patent applications.

Representatives of Israel’s second largest HMO met with Memory Care America executives to discuss how MCA programs and initiatives have paved the way for the future of cognitive care.

Caliber Ophthalmics, a division of Surgical Specialties Corporation (SSC), announced today the global launch of its Sharpoint™ Edge™ Clear Control 3D Plus line of phaco incision knives at the Annual Meeting of the American Academy of Ophthalmology (AAO), to be held October 12-15, 2019 in San Francisco, CA.

Seattle Genetics, Inc. (Nasdaq:SGEN) today announced dosing of the first patient in HER2CLIMB-02, a randomized phase 3 clinical trial evaluating investigational agent tucatinib versus placebo, in combination with standard-of-care ado-trastuzumab emtansine (T-DM1, Kadcyla®), for patients with locally advanced or metastatic HER2-positive (HER2+) breast cancer

Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, announced that Michael Feldschuh, Chief Executive Officer of Daxor, will be a featured presenter at the inaugural MicroCap Rodeo Investor Conference in Austin, Texas at the Hilton Austin on Tuesday, October 15th at 1:30 PM (CT).

The Canadian Skin Patient Alliance is proud to announce the launch of “Patient Charter for Canadians Living with Conditions, Diseases or Traumas involving the Skin.” The intent of the document is to educate and empower patients to take an active role in their care and treatment as well as to safeguard the respect of society, government and workplace as a result of their diagnosis.

The Company is Hiring Additional Staff to Support its Awards Totaling Over $9 Million